Press release
Non-alcoholic steatohepatitis (NASH) Therapeutics & Diagnostics Market: Facts, Figures and Analytical Insights 2019- 2027|Industry Crucial Players - Siemens Healthcare GmbH (ETR: SHL), Celerion, ZyVersa Therapeutics, Inc., Cisbio
Research Nester
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The market for non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics is projected to grow by a significantly high CAGR during the forecast period, i.e., 2019-2027. NASH is a fatty liver disorder caused by the accumulation of excessive amount of fat in the liver among people who consume little or no alcohol. The market is segmented by therapeutics, by diagnostics and by region, out of which, the therapeutics segment is further segmented into ocaliva, elafibranor, cenicriviroc, selonsertib and others. Out of these, the elafibranor segment is estimated to observe the highest growth as a result of high efficacy of this drug in serious cases of the disorder.
On the basis of regional analysis, the market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics market in North America is anticipated to hold the leading share on account of rising technological advancements in the region. This can be attributed to the presence of leading market players in the region who are actively involved in research.
Get Sample PDF Copy of this Report @ https://www.researchnester.com/sample-request-2166
Rising Incidences of Obesity and Diabetes to Influence the Market Growth
According to the World Health Organization, about 1.9 billion adults (above the age of 18) were overweight and out of those, more than 650 million were obese in 2016.
The growing cases of obesity globally might lead to the development of non-alcoholic steatohepatitis, which is anticipated to raise the demand for effective therapeutic and diagnostic method, thereby increasing the market growth over the forecast period. However, the strict regulatory policies by the government and time-consuming process of clinical trials for drugs are estimated to hamper the market growth in the upcoming years.
This report also provides the existing competitive scenario of some of the key players of the global non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics market which includes company profiling of Siemens Healthcare GmbH (ETR: SHL), Celerion, ZyVersa Therapeutics, Inc., Cisbio, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), BioPredictive, Echosens, Genfit (EPA: GNFT), Enterome and NGM Biopharmaceuticals. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
To Know More About This Report Click Here @ https://www.researchnester.com/reports/global-non-alcoholic-steatohepatitis-nash-therapeutics-diagnostics-market/2166
Contact Us
AJ Daniel
Email: sales@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 591
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic steatohepatitis (NASH) Therapeutics & Diagnostics Market: Facts, Figures and Analytical Insights 2019- 2027|Industry Crucial Players - Siemens Healthcare GmbH (ETR: SHL), Celerion, ZyVersa Therapeutics, Inc., Cisbio here
News-ID: 1895751 • Views: …
More Releases from Research Nester Pvt Ltd
Fraud Management In Banking Market Leaders - Competitive Positioning, Strategic …
The fraud management in banking market is evolving rapidly as digital transformation reshapes the global financial ecosystem. With the proliferation of online banking, real-time payments, and mobile transactions, banks face growing challenges from sophisticated cyber threats. As financial institutions intensify their efforts to secure customer data and protect assets, fraud management solutions are becoming indispensable. This article provides an in-depth analysis of the leading companies, their competitive positioning, and emerging…
Gunshot Detection Systems Market - Top Competitors, SWOT Deep Dive & Capital Flo …
The gunshot detection systems market has become increasingly vital in the global public safety ecosystem. As threats from urban violence, mass shootings, and cross-border terrorism persist, law enforcement agencies, defense forces, and private organizations are turning to advanced acoustic and infrared-based gunshot detection technologies for real-time situational awareness. These systems are being integrated into smart city frameworks, critical infrastructure, and defense surveillance networks, transforming the landscape of security intelligence.
This article…
Top Companies in Smartwatch Battery Market - Benchmarking Performance & Future V …
The smartwatch battery market is evolving rapidly, shaped by advancements in wearable technology, growing health-conscious consumers, and rising integration of AI-driven features. As global demand for smartwatches accelerates, battery technology has become the cornerstone of innovation and competitiveness. This article explores the leading players driving advancements in smartwatch battery technology, a detailed SWOT analysis of industry leaders, and the emerging investment opportunities reshaping the market landscape.
➤ Request Free Sample PDF…
Key Players in the Precision Gearbox Market: Share Positioning & Investor Perfor …
The precision gearbox market has emerged as a critical enabler of motion control and automation technologies across industrial robotics, aerospace, automotive, and semiconductor manufacturing sectors. As demand for high-performance, compact, and efficient drive systems continues to rise, companies in this space are leveraging innovation, digitalization, and material advancements to strengthen their competitive positions. This article provides an in-depth strategic analysis of leading companies, a collective SWOT assessment, and the latest…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
